Reading this field carefully
Three habits make the literature much easier to read honestly.
Look at sample size. A great deal of what gets cited confidently rests on studies of a few dozen people. Look at who was included. Trial participants are usually screened far more rigorously than ceremony participants, which limits how far the results transfer. And look at who is reporting. Much of this research is conducted by people who are invested in the outcome, which does not make it wrong but does mean independent replication matters.
Expectancy is the persistent methodological problem. Blinding barely works when participants can tell which group they are in, and that inflates effects in ways nobody has fully solved.
Reasonably supported
A few things have decent support, though none of them at the strength of established medical treatments.
That preparation and context shape outcomes substantially. The influence of expectation, setting, and relationship on the character of an experience is one of the more consistent findings across this literature, and it is the finding most relevant to how anyone practises.
That psychological support around these experiences matters to how they resolve. Trials in this area are built around preparation and follow-up sessions rather than the substance alone, which is an implicit acknowledgement that the surrounding work is doing part of the job.
That serious adverse events are uncommon in carefully screened clinical settings, and that this finding does not transfer cleanly to unscreened settings.
Promising but preliminary
Clinical results in depression, PTSD, and substance dependence have been genuinely encouraging in early trials, with effect sizes that warranted the attention they received. They remain early. Sample sizes are small, long-term follow-up is limited, and some larger or independent studies have produced more modest results than the first wave.
Durability is the open question. Several studies show benefits at six months. Far fewer follow people for years, and the ones that do show more variation than the headlines suggest.
Where the evidence is thin
- Integration. Almost everyone agrees it matters. There is very little controlled research on what specific integration practices actually help, which means most integration protocols, including ours, rest on clinical judgement rather than trial data.
- Group and ceremonial settings. Nearly all the clinical evidence comes from individual sessions in medical environments. Most real-world practice is neither.
- Repeat participation. Little is known about the effects of frequent participation over years, which is now common.
- Long-term outcomes in unscreened populations. Effectively unstudied, despite being where most people's experience actually happens.
- Adverse events outside trials. No systematic reporting mechanism exists, so the denominator is unknown and the harms are undercounted by default.
Claims to be sceptical of
Statements presented as established that are not: that these practices cure any condition; that they are safe for everyone; that a single experience produces permanent change; that any specific percentage of people are helped, quoted without the study, the sample, and the follow-up period; that ancient peoples used a given practice in the way it is used today, where the archaeological record is genuinely contested.
When you encounter a striking number, ask which study, how many participants, screened how, and followed for how long. The answer is often much smaller than the claim.
What this means for practice
The honest position is that this field is promising and unfinished, that the strongest evidence concerns the surrounding conditions rather than any substance in isolation, and that careful preparation and integration are the parts most defensible on the current record.
Which is, not coincidentally, what this school teaches. We say where the evidence is thin because a student who inherits false certainty from us will pass it on to someone who is making a decision about their own life.